UPDATED TOPIC - Virtual press conference on global health issues, with focus on launch of WHO guideline concerning glucagon-like peptide-1 (GLP-1) therapies and obesity in adults

No images? Click here Wednesday, 26 November 2025  MEDIA ADVISORY  UPDATED TOPIC: Virtual press conference on global health issues, with focus on launch of WHO guideline concerning  glucagon-like peptide-1 (GLP-1) therapies and obesity in adults   WHEN: 14.30 CET/13.30 GMT on Monday, 1 December 2025   Hosted by: Dr Tedros Adhanom Ghebreyesus, WHO Director-General Subjects: Launch of the first WHO guideline concerning GLP-1 therapies and obesity in adults, and other global health issues. Join via Zoom: Link: https://who.zoom.us/j/94560176083 Password: 12WHO&vpc1 Join by phone: International numbers available:https://who.zoom.us/u/aceOXSswaf Webinar ID: 945 6017 6083 Numeric passcode for phone:4179408447 Notes to journalists: Please enter your name and media outlet (use name/outlet) in your Zoom profile and ensure your microphone is connected and active on your computer.  When you sign in, you will be automatically put in the meeting room. Click "raise hand" if you wish to ask a question (the icon can be found under the tab: participants), this will enter you into the queue for questions.  Please note that only questions from the media are allowed during the press conference.  The event will also be broadcast on WHO social media channels, and you can follow it there.  Media contacts: mediainquiries@who.int   You are receiving this NO-REPLY email because you are included on a WHO mail list. If you have been forwarded this update you can click here to subscribe. Journalists may send feedback to WHO Media Team       Share    Tweet    Share    Forward  World Health Organization, Avenue Appia 20, 1202 Geneva 27, Switzerland  Preferences  |  Unsubscribe